Health & Medicine
Browse conferences on Health & Medicine.
2025 Electrophysiology Online Board Review
#_EVENTSTARTDATE
20 Nov - 19 Nov 2025, 7:00 am - 4:30 pm
The 2025 Electrophysiology Online Board Review offers concise, expert-led updates across the full EP spectrum and personalized learning tools...
5th LNP Formulation and Process Development Summit
#_EVENTSTARTDATE
06 Apr - 08 Apr 2026, 8:00 am - 5:00 pm
LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics,...
Live Webinar Adult-Gerontology Primary Care Nurse Practitioner BLITZ Certification Review and Clinical Update Continuing Education Course
#_EVENTSTARTDATE
08 Apr - 10 Apr 2026, 12:30 pm - 2:15 am
The Adult-Gerontology Primary Care NP BLITZ Certification Review & Clinical Update is a 3-day intensive live webinar designed to...
Mayo Clinic Critical Care Review for the Nurse Practitioner and Physician Associate 2026
#_EVENTSTARTDATE
09 Apr - 11 Apr 2026, 7:30 am - 3:00 pm
Mayo Clinic's Critical Care Review for the Nurse Practitioner and Physician Associate is an interactive course designed for advanced...
5th Annual Innovations in Management of Pancreatic Conditions and Therapies
#_EVENTSTARTDATE
11 Apr 2026, 7:00 am - 4:40 pm
This one-day course features expert-led presentations on the latest advances in managing benign and malignant pancreatic diseases. Designed to...
8th Neuroimmunology Drug Development Summit
#_EVENTSTARTDATE
14 Apr - 16 Apr 2026, 9:00 am - 5:00 pm
Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil's TREM2 asset, Ventus' NLRP3 inhibitor in phase...
8th Neuroimmunology Drug Development Summit at Boston, MA
#_EVENTSTARTDATE
14 Apr - 16 Apr 2026, 9:00 am - 5:00 pm
Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil’s TREM2 asset, Ventus’ NLRP3 inhibitor in phase...
8th Neuroimmunology Drug Development Summit at Wyndham Boston Beacon Hill
#_EVENTSTARTDATE
14 Apr - 16 Apr 2026, 9:00 am - 5:00 pm
Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil’s TREM2 asset, Ventus’ NLRP3 inhibitor in phase...
4th Lab Operations and Facility Management for Biopharma Summit
#_EVENTSTARTDATE
15 Apr - 16 Apr 2026, 8:00 am - 3:30 pm
The 4th Lab Operations and Facility Management for Biopharma Summit is Europe’s only meeting dedicated exclusively to the operational...